Treatment initiations and opioid overdoses among recently incarcerated people after adoption of the take-home methadone policy

IF 3.6 2区 医学 Q1 PSYCHIATRY
Benjamin A. Barsky , Shapei Yan , Meredith B. Rosenthal
{"title":"Treatment initiations and opioid overdoses among recently incarcerated people after adoption of the take-home methadone policy","authors":"Benjamin A. Barsky ,&nbsp;Shapei Yan ,&nbsp;Meredith B. Rosenthal","doi":"10.1016/j.drugalcdep.2025.112775","DOIUrl":null,"url":null,"abstract":"<div><div>Opioid overdose is the leading cause of death among recently incarcerated people. Take-home methadone flexibilities adopted at the COVID-19 pandemic’s outset may have facilitated opioid use disorder treatment initiations and prevented opioid overdoses for this population. These flexibilities may have particularly enhanced treatment initiations for rural residents, given relaxed in-person methadone treatment requirements. Leveraging the Massachusetts Department of Public Health’s Public Health Data Warehouse, we assessed whether the Massachusetts take-home methadone policy was associated with changes in post-release initiations of medications for opioid use disorder (MOUD) (i.e., methadone, buprenorphine, and extended-release naltrexone) and opioid overdoses among recently released people, including rural residents. Results show that the monthly initiation rate of any MOUD within 7 days of release did not change after the policy. However, when disaggregating by MOUDs, we find a trend divergence, with increases in methadone offsetting decreases in other MOUDs. After the policy, the monthly rate of methadone initiations increased significantly. By contrast, the monthly rate of buprenorphine initiations decreased, and the monthly rate of extended-release naltrexone initiations remained stable. These patterns generally held among rural residents, who experienced significantly higher methadone initiation rates relative to urban residents after the policy. Furthermore, in contrast to increased opioid overdose rates in Massachusetts and the United States during the pandemic, the monthly adjusted rate of fatal and non-fatal opioid overdoses within 90 days of release remained stable. These findings suggest that take-home methadone flexibilities may facilitate methadone initiations for recently incarcerated individuals, particularly rural residents, and potentially prevent opioid overdoses.</div></div>","PeriodicalId":11322,"journal":{"name":"Drug and alcohol dependence","volume":"274 ","pages":"Article 112775"},"PeriodicalIF":3.6000,"publicationDate":"2025-07-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Drug and alcohol dependence","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0376871625002285","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PSYCHIATRY","Score":null,"Total":0}
引用次数: 0

Abstract

Opioid overdose is the leading cause of death among recently incarcerated people. Take-home methadone flexibilities adopted at the COVID-19 pandemic’s outset may have facilitated opioid use disorder treatment initiations and prevented opioid overdoses for this population. These flexibilities may have particularly enhanced treatment initiations for rural residents, given relaxed in-person methadone treatment requirements. Leveraging the Massachusetts Department of Public Health’s Public Health Data Warehouse, we assessed whether the Massachusetts take-home methadone policy was associated with changes in post-release initiations of medications for opioid use disorder (MOUD) (i.e., methadone, buprenorphine, and extended-release naltrexone) and opioid overdoses among recently released people, including rural residents. Results show that the monthly initiation rate of any MOUD within 7 days of release did not change after the policy. However, when disaggregating by MOUDs, we find a trend divergence, with increases in methadone offsetting decreases in other MOUDs. After the policy, the monthly rate of methadone initiations increased significantly. By contrast, the monthly rate of buprenorphine initiations decreased, and the monthly rate of extended-release naltrexone initiations remained stable. These patterns generally held among rural residents, who experienced significantly higher methadone initiation rates relative to urban residents after the policy. Furthermore, in contrast to increased opioid overdose rates in Massachusetts and the United States during the pandemic, the monthly adjusted rate of fatal and non-fatal opioid overdoses within 90 days of release remained stable. These findings suggest that take-home methadone flexibilities may facilitate methadone initiations for recently incarcerated individuals, particularly rural residents, and potentially prevent opioid overdoses.
采用美沙酮带回家政策后,最近被监禁的人的治疗起始和阿片类药物过量
阿片类药物过量是最近被监禁的人死亡的主要原因。在COVID-19大流行开始时采取的美沙酮带回家灵活性可能促进了阿片类药物使用障碍治疗的启动,并防止了这一人群的阿片类药物过量使用。鉴于美沙酮现场治疗要求的放宽,这些灵活性可能特别提高了农村居民的治疗启动率。利用马萨诸塞州公共卫生部的公共卫生数据仓库,我们评估了马萨诸塞州的美沙酮带回家政策是否与最近释放的人(包括农村居民)中阿片类药物使用障碍(mod)(即美沙酮、丁丙诺啡和缓释纳曲酮)药物释放后开始使用阿片类药物的变化有关。结果表明,在政策实施后,任何mod在发布后7天内的月启动率均未发生变化。然而,当按药物种类进行分类时,我们发现了一种趋势分歧,美沙酮的增加抵消了其他药物种类的减少。政策实施后,每月美沙酮起始率显著增加。相比之下,丁丙诺啡的月起始率下降,而缓释纳曲酮的月起始率保持稳定。这些模式在农村居民中普遍存在,政策实施后,农村居民的美沙酮起始率明显高于城市居民。此外,与大流行期间马萨诸塞州和美国阿片类药物过量率上升相反,在释放后90天内致命和非致命阿片类药物过量的月度调整率保持稳定。这些发现表明,带回家的美沙酮灵活性可能有助于最近被监禁的个体,特别是农村居民开始使用美沙酮,并可能防止阿片类药物过量使用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Drug and alcohol dependence
Drug and alcohol dependence 医学-精神病学
CiteScore
7.40
自引率
7.10%
发文量
409
审稿时长
41 days
期刊介绍: Drug and Alcohol Dependence is an international journal devoted to publishing original research, scholarly reviews, commentaries, and policy analyses in the area of drug, alcohol and tobacco use and dependence. Articles range from studies of the chemistry of substances of abuse, their actions at molecular and cellular sites, in vitro and in vivo investigations of their biochemical, pharmacological and behavioural actions, laboratory-based and clinical research in humans, substance abuse treatment and prevention research, and studies employing methods from epidemiology, sociology, and economics.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信